Discover
VANI
Vivani Medical, Inc.
1.23
2 x 0.88
2 x 1.56
bid
ask
-
0.01
0.81%
2 @ 04:00 PM
1.26 +0.03 (2.83%)
| Ytd | 0.00% | |
| 1y | -2.38% |
1.20
day range
1.25
0.92
52 week range
1.92
| Open | 1.20 | Prev Close | 1.24 | Low | 1.20 | High | 1.25 | Mkt Cap | 106.07M |
| Vol | 48.84K | Avg Vol | 222.42K | EPS | -0.40 | P/E | N/A | Forward P/E | -2.11 |
| Beta | 3.52 | Short Ratio | 12.59 | Inst. Own | 10.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.23 | 200-d Avg | 1.31 | 1yr Est | 5.50 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | 0 | -0.11 | N/A | N/A |
| 2024-08-13 | 2024-06 | 0 | -0.1 | N/A | N/A |
| 2024-05-13 | 2024-03 | 0 | -0.12 | N/A | N/A |
| 2024-03-26 | 2023-12 | 0 | -0.12 | N/A | N/A |
| 2023-11-14 | 2023-09 | 0 | -0.13 | N/A | N/A |
| 2023-08-14 | 2023-06 | 0 | -0.13 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-07 | HC Wainwright & Co. | Upgrade | Buy | |
| 2022-12-05 | ThinkEquity | Upgrade | Buy |
Profile
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-01-02 | BOLCK JOACHIM EBERHARD | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
| 2024-10-02 | DWYER DONALD | Officer | 50.00K | Purchase |
| 2023-04-17 | LARSON ALEXANDRA L.P. | Beneficial Owner of more than 10% of a Class of Security | 2.17K | Stock Award(Grant) |
| 2023-12-17 | MAKES BRIGID A | Chief Financial Officer | 15.00K | Purchase |
| 2023-06-08 | MENDELSOHN AARON | Director | 188.17K | Purchase |
| 2023-02-07 | MENDELSOHN ADAM | Chief Executive Officer | 3.61M | Stock Gift |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Sabby Management, LLC | 2.13M | 2.51M | 3.59% |
| 2024-09-29 | Tanager Wealth Management LLP | 1.30M | 1.54M | 2.20% |
| 2024-09-29 | Vanguard Group Inc | 967.40K | 1.14M | 1.63% |
| 2024-09-29 | Geode Capital Management, LLC | 342.89K | 404.61K | 0.58% |
| 2024-09-29 | Commonwealth Equity Services, LLC | 330.53K | 390.03K | 0.56% |
| 2024-09-29 | Monetary Management Group, Inc. | 193.98K | 228.89K | 0.33% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 636.70K | 751.31K | 1.07% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 314.42K | 371.01K | 0.53% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 175.61K | 207.22K | 0.30% |
| 2024-10-30 | Fidelity Total Market Index Fund | 51.79K | 61.11K | 0.09% |
| 2024-10-30 | iShares Micro Cap ETF | 47.98K | 56.62K | 0.08% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 41.50K | 48.97K | 0.07% |
Split
| Split | Date |
|---|---|
| 1 : 3 | 2022-08-19 |
| 1 : 8 | 2020-01-06 |